We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining
J Int Med Res 2005, PMID: 16104441

Hydroxyethyl starch inhibits intestinal production of cytokines and activation of transcription factors in endotoxaemic rats.

Lv, R; Zhou, W; Yang, J J; Jin, Y; Xu, J G

We studied the effect of hydroxyethyl starch (HES) on intestinal production of cytokines and activation of transcription factors in sepsis. Septic rats, induced by intraperitoneal lipopolysaccharide (LPS) (5 mg/kg), were treated with intravenous HES (16 ml/kg) or saline (64 ml/kg). Rat ileal tissues were collected at 2 h, 3 h or 6 h after LPS challenge. Levels of tumour necrosis factor alpha (TNF-alpha), interleukin (IL) 1beta, IL-6, IL-8 and IL-10, cytokine mRNAs, activities of nuclear factor kappa-B (NF-KB) and activator protein-1 (AP-1), and the number of ileal myeloperoxidase (MPO)-positive cells were determined for each group. HES significantly reduced the LPS-induced increase in intestinal levels of TNF-alpha, IL-1beta, IL-6, IL-8 and their corresponding mRNAs. HES also decreased the number of MPO-positive cells induced by LPS and inhibited activation of NF-kappaB and AP-1. The results suggest that in sepsis, HES may down-regulate intestinal pro-inflammatory cytokine production via suppression of NF-kappaB and AP-1 activation.

Diseases/Pathways annotated by Medline MESH: Endotoxemia, Sepsis
Document information provided by NCBI PubMed

Text Mining Data

TNF-alpha ⊣ HES: " HES significantly reduced the LPS induced increase in intestinal levels of TNF-alpha , IL-1beta, IL-6, IL-8 and their corresponding mRNAs "

IL-1beta ⊣ HES: " HES significantly reduced the LPS induced increase in intestinal levels of TNF-alpha, IL-1beta , IL-6, IL-8 and their corresponding mRNAs "

IL-6 ⊣ HES: " HES significantly reduced the LPS induced increase in intestinal levels of TNF-alpha, IL-1beta, IL-6 , IL-8 and their corresponding mRNAs "

IL-8 ⊣ HES: " HES significantly reduced the LPS induced increase in intestinal levels of TNF-alpha, IL-1beta, IL-6, IL-8 and their corresponding mRNAs "

TNF-alpha → LPS: " HES significantly reduced the LPS induced increase in intestinal levels of TNF-alpha , IL-1beta, IL-6, IL-8 and their corresponding mRNAs "

IL-1beta → LPS: " HES significantly reduced the LPS induced increase in intestinal levels of TNF-alpha, IL-1beta , IL-6, IL-8 and their corresponding mRNAs "

IL-6 → LPS: " HES significantly reduced the LPS induced increase in intestinal levels of TNF-alpha, IL-1beta, IL-6 , IL-8 and their corresponding mRNAs "

IL-8 → LPS: " HES significantly reduced the LPS induced increase in intestinal levels of TNF-alpha, IL-1beta, IL-6, IL-8 and their corresponding mRNAs "

AP-1 ⊣ HES: " HES also decreased the number of MPO positive cells induced by LPS and inhibited activation of NF-kappaB and AP-1 "

NF-kappaB ⊣ HES: " HES also decreased the number of MPO positive cells induced by LPS and inhibited activation of NF-kappaB and AP-1 "

Manually curated Databases

No curated data.